Biotech’s Summer Surge: From Historic IPOs to AI-Driven Discovery and Genetic Breakthroughs
The biotechnology sector is experiencing a period of intense activity, marked by a rare combination of massive capital infusion, strategic...
historic
Parabilis Medicines Shatters Records with Historic $770.5 Million IPO, Signaling Biotech Resurgence
In a watershed moment for the life sciences sector, Cambridge-based Parabilis Medicines (Nasdaq: PBLS) has officially cemented its position at...
